Overview

• The program organizes collaboration across three pillars—Discovery, Validation, and Deployment—with infrastructure to integrate solutions across Mayo Clinic’s U.S. and international network.
• Collaborators can access longitudinal, multimodal real-world data powered by nference to accelerate product pipelines and real-world evidence generation.
• Mayo Clinic describes the initiative as the front door to its platform ecosystem, offering de-identified clinical data, physician-scientist expertise, and an international partner network.
• Early work focuses on multimodal AI for early disease detection, precise patient identification for targeted therapies, faster and more diverse clinical trial recruitment, and scaled deployment of validated digital health tools.
• Chief operating officer Maneesh Goyal says the aim is to help life sciences and biopharma partners bring therapies to patients safely and faster by combining trusted data, advanced AI, and Mayo Clinic’s scientific expertise.